Epigenomics AG (FRA:ECX)
Germany · Delayed Price · Currency is EUR 0.8700
-0.2200 (-20.18%)
May 14, 2026, 8:13 PM CET
Epigenomics AG Market Cap
Epigenomics AG has a market cap or net worth of €815.59 thousand as of May 14, 2026. Its market cap has decreased by -7.00% in one year.
Market Cap
815.59K
Enterprise Value
11.78M
Revenue
24.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.87
Market Cap Chart
Since September 22, 2014, Epigenomics AG's market cap has decreased from 52.02M to 815.59K, a decrease of -98.43%. That is a compound annual growth rate of -30.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 815.59K | 3.34% |
| Dec 30, 2025 | 789.25K | -19.48% |
| Dec 30, 2024 | 980.17K | -38.24% |
| Dec 29, 2023 | 1.59M | -76.50% |
| Dec 30, 2022 | 6.75M | -17.48% |
| Dec 30, 2021 | 8.18M | -57.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 49.06B |
| Siemens Healthineers AG | 37.53B |
| Bayer Aktiengesellschaft | 36.33B |
| Fresenius SE & Co. KGaA | 23.07B |
| aap Implantate AG | 28.65M |
| Maternus-Kliniken Aktiengesellschaft | 21.39M |
| NanoRepro AG | 18.92M |
| Biofrontera AG | 14.83M |